Astaxanthin for skin: hydration and elasticity
What a 16-week astaxanthin study found about skin hydration and elasticity.
Key points
- In healthy women aged 35–60 with wrinkles around the eyes, 6 or 12 mg astaxanthin daily for 16 weeks showed no significant advantage over placebo for skin hydration. No additional improvement in the measured outcome was found for this group. [1] See the evidence 1
- The same study also found no advantage for skin elasticity measured in three ways. These results apply to the specific oil extract and course. [1] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Astaxanthin was studied in women with wrinkles around the eyes. Skin hydration and elasticity were measured separately.
Key points
Why these conclusions
Skin hydration and elasticity
Healthy women aged 35–60 with wrinkles around the eyes received softgels of Haematococcus pluvialis oil extract containing 6 or 12 mg astaxanthin daily, or capsules with the same oil base without astaxanthin. After 16 weeks no significant advantage in hydration was found. [1]
No significant advantage over placebo was found for three skin-elasticity measures either. Both outcomes come from one publication; confidence is low, 2 out of 4. [1]
Over 16 weeks, doses of 6 and 12 mg daily showed no significant advantage over placebo for skin hydration.
| Parameter | Data |
|---|---|
| Result | Over 16 weeks, doses of 6 and 12 mg daily showed no significant advantage over placebo for skin hydration. |
| Participants | 65 healthy women aged 35–60 with wrinkles around the eyes; 59 were analysed |
| Form | AstaReal Oil 50F: Haematococcus pluvialis oil extract in softgels |
| Dose | 6 or 12 mg astaxanthin daily in separate groups |
| Dose basis | 6 or 12 mg astaxanthin daily in separate groups |
| Comparator | Capsules without astaxanthin in the same oil base |
| Duration | 16 weeks |
| Confidence | 2/4: Six participants were not included in the analysis; there are links to the manufacturer. Changes from baseline and individual subgroups do not establish an overall advantage. The small sample leaves uncertainty about the size of a possible difference. |
| Evidence base | 1 publication |
| Sources | [1] |
Over 16 weeks, doses of 6 and 12 mg daily showed no significant advantage over placebo for skin elasticity measured by three outcomes.
| Parameter | Data |
|---|---|
| Result | Over 16 weeks, doses of 6 and 12 mg daily showed no significant advantage over placebo for skin elasticity measured by three outcomes. |
| Participants | 65 healthy women aged 35–60 with wrinkles around the eyes; 59 were analysed |
| Form | AstaReal Oil 50F: Haematococcus pluvialis oil extract in softgels |
| Dose | 6 or 12 mg astaxanthin daily in separate groups |
| Dose basis | 6 or 12 mg astaxanthin daily in separate groups |
| Comparator | Capsules without astaxanthin in the same oil base |
| Duration | 16 weeks |
| Confidence | 2/4: Six participants were not included in the analysis; there are links to the manufacturer. Changes from baseline and individual subgroups do not establish an overall advantage. The small sample leaves uncertainty about the size of a possible difference. |
| Evidence base | 1 publication |
| Sources | [1] |
Information from the source
During pregnancy and breastfeeding, discuss the supplement with a doctor before starting; a Health Canada monograph includes this instruction. The European safety assessment for astaxanthin from Haematococcus pluvialis considers both supplements and food. In its calculation, 8 mg from a supplement together with high dietary intake was within the acceptable level for adults; the same scenario exceeded it in children under 14. This is not a paediatric dose. The 28 mg dose in a short cycling trial describes four days of experience, not a safe long-term regimen. If taking warfarin, agree use of the supplement in advance with the doctor monitoring blood clotting. Unusual bruising or bleeding requires medical attention. [2] [3] [4]
Sources
- Protective effects of astaxanthin on skin deterioration. https://pubmed.ncbi.nlm.nih.gov/28751807/
- Safety of astaxanthin for its use as a novel food in food supplements. https://pubmed.ncbi.nlm.nih.gov/32874213/
- Interaction between warfarin and astaxanthin: A case report. https://pubmed.ncbi.nlm.nih.gov/31073352/
- Antioxidants — Health Canada monograph, 26 June 2026. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=antiox&lang=eng
Methodology: Subpages evidence-led supplement pipeline v1